Bush's Pandemic Avian Flu Proposal has an Unethical Corporate Link

As the credibility begins to crumble around the current regime in the United States Whitehouse, the president recently laid out a plan to help suppress the threat of a so-called flu pandemic (Avian Flu). This elaborate Pandemic Influenza Plan calls for congress to allot approximately 7.1 billion dollars to properly prepare for such an event. The most interesting element of Bush’s Pandemic Proposal is the need to stockpile medical supplies, particularly the anti-viral drug Tamiflu, for a potential outbreak of the virus in the U.S. 

According to the president, Tamiflu aids, not cures, the symptoms of Avian Flu if taken 48 hours after infection. For this reason, Bush’s plan calls for a stockpile of 80 million doses of the anti-viral drug; at a cost of 2 billion dollars. So the obvious question is, “Why Tamiflu?” The reason might be more sinister than one can palate.

A doctor and notable author Dr. Joseph Mercola recently said that Tamiflu “is a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations.” And yet, the president still allotted a substantial portion of the money in his Pandemic initiative to the stockpile of this useless drug. Could it be that this president is not telling the U.S. people something? If one does enough research, they’ll realize the true motivation for this spread of Pandemic fear.

Tamiflu is currently being manufactured by the pharmaceutical company Roche. But if one investigates further, they’ll find that a company by the name of Gilead actually developed this anti-viral drug. As a result, Gilead gave Roche exclusive rights to market, manufacture and distribute the drug about ten years ago. These crucial facts are very important because a motive begins to evolve out of knowing them.